Quallion LLC, a world leader in the development of customized high quality lithium ion batteries for medical, military, aerospace, and vehicle applications, announced that it had submitted a proposal to the U.S. Department of Energy (DOE) for a grant under the Recovery Act ? Electric Drive Vehicle Battery and Component Manufacturing Initiative.
Dr. Graciela Blanchet, a pioneer in the field of organic electronics, has been named Chief Technology Officer at Nano Terra, Inc., a leading surface engineering and nanotechnology development company based in Cambridge, Massachusetts.
New Energy Technologies, Inc. today announced that, in addition to the active development of its MotionPower technologies for generating electricity by harvesting the kinetic energy of moving vehicles, the Company is continuing to further advance the development of its tinted transparent glass SolarWindows capable of generating electricity by coating glass surfaces with the world's smallest known organic solar cells.
Dresden-based Namos GmbH, a portfolio company of Nanostart AG, has reached the final round of the IQ Innovation Awards for Central Germany with its project 'Saving of precious metals in catalytic converters using a biological template'.
Nanometrics Incorporated, a leading supplier of advanced process control metrology systems used primarily in the manufacturing of semiconductors, solar photovoltaics and high-brightness LEDs, today announced the shipment of a Lynx cluster metrology system.
nanoTox, the first company to provide complete risk assessment exclusively for nanoparticles, announced today that Gary W. Pankonien has joined the company as Chief Executive Officer and Vice Chairman of the Board. Mr. Pankonien was formerly CEO for the nanoparticle firm, Nanotechnologies (now NovaCentrix), a provider of custom engineered nanopowders.
Carbon Sciences Inc., the developer of a breakthrough technology to recycle carbon dioxide (CO2) emissions into gasoline and other fuels, today announced significant technology development breakthroughs that shorten the path to commercializing its CO2-to-Fuel technology.
NanoViricides, Inc., announced today that the Institutional Review Committee of a major research institute in New York has approved an investigator-initiated in vivo study which will evaluate certain topical nanoviricide eye drug candidates.
All Zeiss suppliers were evaluated based on a criteria catalog containing the four main categories of quality, technology, logistics and pricing, as well as additional sub-criteria. M+W Zander had the best overall average.